The Barcelona HPV Course 2024

Adrià Curran is a staff physician of the Infectious Diseases Department of the Vall d’Hebron University Hospital and is the coordinator of the Anal Dysplasia Screening Unit of Vall d’Hebron University Hospital. He has carried out specific training on HPV anal dysplasia in HIV patients at the University of San Francisco (CA, USA) with Prof. Joel Palefsky. He is a member of the International Anal Neoplasia Society. He participates as a researcher in multiple international clinical trials and has published more than 100 articles in national and international journals and book chapters on various aspects of HIV infection, HPV and its treatment.

Degree in Medicine and Surgery from the Autonomous University of Barcelona and Doctor of Medicine from the University of Barcelona.
Colorectal surgeon at the Hospital Universitari Germans Trias i Pujol, Badalona (Barcelona).

Specialist in Anatomic Pathology (2006).
PhD in Morphology and Structural and Molecular Pathology from the Autonomous University of Barcelona (UAB) (2017).
Specialist in Cytology and Ocular Pathology.
Currently Coordinator of the Cytology Section of the Anatomic Pathology Service of the Vall d’Hebron University Hospital in Barcelona, Spain.
Outgoing President of the Catalan Society of Cytopathology.
Vice-President of the Spanish Society of Cytology.
Member of the European Ophthalmic Pathology Society (EOPS).

Fernando Dias Gonçalves Lima is a physician in the Dermatology department and a PhD candidate at Amsterdam UMC. His PhD research focuses on biomarkers in anal cancer screening, with a particular emphasis on methylation markers. Fernando is the coordinating researcher of the MARINE study, a large cohort study aimed at validating methylation markers in people with anal dysplasia. In addition to his research, he is a skilled high-resolution anoscopist and conducts weekly clinics.

Dr. Francesc García Cuyàs is a Doctor in Digestive System Surgery, currently Deputy Chief Medical Officer and Chief of Digital Transformation at the Sant Joan de Déu Hospital in Barcelona. He is an accredited associate professor at the Faculty of Medicine of the UVIC-UCC and the Autonomous University of Barcelona, and President of the Catalan Society of Digital Health.
For 5 years he has been director of the Social Health ICT Foundation, and director of the ICT and Health Chair at the UVIC-UCC, General Coordinator of ICTs of the Department of Health of the Generalitat de Catalunya, Master by ESADE in Management of Integrated Services of Health, director of the Strategic Secretary and Information Systems of the Institut Català de la Salut from two years. He was also director of the Argos project at the Germans Trías i Pujol Hospital and deputy of the Surgery Service of the same hospital.

Fight Infections Foundation, HUGTiP, Badalona.

Specialist in Dermatology and Venereology trained at the Hospital Clínic in Barcelona.

She currently works as a senior specialist in the Dermatology Service of this centre, focusing on the area of sexually transmitted infections and neoplastic pathology related to HPV.

She has more than 9 years experience in screening for anal canal dysplasia in patients at high risk for anal cancer and she has published several research papers in national and international journals especially in the field of sexually transmitted infections.

She is also the head of the STI and HIV Research Group of the AEDV (Spanish Academy of Dermatology) since 2022.

Javier Corral, is a general and digestive system surgeon trained at the Germans Trias i Pujol Hospital in Badalona in 2018.
Currently attending surgeon at this center and devotes his time in the field of coloproctology, with special interest in the field of proctology, pelvic floor pathology and colorectal cancer.
At the end of his residency at the Hospital he was awarded a postresidency grant, thanks to the “Premis Talents” program, with a multidisciplinary research project on fecal incontinence as a sequela in ischemic stroke, performing among other physiological and anatomical studies with manometry and anal ultrasound.
He also participates as a collaborating proctologist in the “Fundació Lluita contra la Sida” with the screening of anal dysplastic lesions with high resolution anoscopy and treating them with topical or infrared treatments. This field is the focus of his thesis project, for which he obtained Excellent Cum Laude in 2021.
In 2022 he decided to start a Postgraduate Degree in Clinical Sexology since his clinical practice in anal dysplasia consultation has led him to treat many patients of the LGTBIQ+ collective and to see the importance of sex and sexual and anal health in this population. Thus, being able to treat with more knowledge, tolerance and respect.
Since December 2021, he has been dedicated to the dissemination and awareness of Anal and Sexual Health in the LGTBIQ+ collective through instragram, with already more than 12.000 followers (@drcorralproctologia).

Joel Palefsky, M.D., C.M., F.R.C.P.(C). Professor of Medicine and Infectious Diseases at the University of California San Francisco School of Medicine. He is an internationally recognized expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the director of the world’s first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center. He is the vice-chair of the National Cancer Institute (NCI)-supported AIDS Malignancy Consortium. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study, a national multi-site NIH study designed to determine whether treatment of anal cancer precursor lesions prevents the development of anal cancer and to identify biomarkers of progression. He is founder and past president of the International Anal Neoplasia Society and is past president of the International Papillomavirus Society. He is the founder and chairperson of the IPVS International HPV Awareness Campaign.

Medical specialist in internal medicine. He is currently performing his assistance in the area of infectious diseases, specifically in HIV and STIs in the Drassanes Unit – Vall d’Hebron University Hospital, in Barcelona. His areas of expertise are combined HIV prevention, the approach to recreational drug use in sexualized contexts (Chemsex) and anal dysplasia screening.

Jose Luis Blanco is a consultant at the HIV / AIDS Unit and Infectious Disease Service, Associate Professor University of Barcelona since 2015 and Professor del Master of AIDS University of Barcelona since 2002. He is Consultant in Charge of the Research in HIV Resistance and Rescue Therapies, Sexually Transmission Diseases Unit and Program of Anal Canal Prevention Program and he  is author of more than 100 scientific articles and the principal investigator of national and international projects in the field of HIV infection and related infections.

Laia Alemany holds a Medicine degree (University of Barcelona-UB, 2000), a speciality in Preventive Medicine and Public Health (Vall d’Hebron University Hospital, 2005), a Master in Epidemiology and Public Health (Pompeu Fabra University-UPF, 2005), and a Master in Molecular Oncology (Spanish National Cancer Research Center-CNIO, 2017).

Associate physician of the Infectious Diseases Service of the Bellvitge University Hospital. She works in the HIV and STI Unit where she carries out care and research work in the field of HPV and HIV-related comorbidities.

Degree in Medicine and Surgery from the Autonomous University of Barcelona (1999). Specialist in Preventive Medicine and Public Health since 2004; Master in Public Health and Epidemiology from the Universitat Pompeu Fabra-Universitat Autònoma de Barcelona since 2002; Head of the Department of Preventive Medicine and Epidemiology at the Hospital Universitari Vall d’Hebron since October 2022; Associate Professor at the Universitat Autònoma de Medicina since 2005. Co-director of the annual course Update in Immunizations of the Hospital Universitari Vall d’Hebron since 2022. Professional career focused on vaccination of high-risk patients and population-based cancer screening programs.